DSEN Funding

The Drug Safety and Effectiveness Network (DSEN) funds health research in order to develop and support a well-trained base of investigators with the skills and expertise needed to design and conduct innovative and diverse research and knowledge translation activities aimed at improving health.

2013 Funding Decisions

Funding Opportunity Competition Funding Decision
Fellowship: Fall 2013 Priority Announcement (Drug Safety and Effectiveness) 201311FDS View
Doctoral Research Award: Fall 2013 Priority Announcement (Drug Safety and Effectiveness) 201310DRS View
Operating Grant: Fall 2013 Priority Announcement (Drug Safety and Effectiveness (Bridge Funding)) 201309DRB View
Other: Rapid Funding for DSEN Targeted Research - 2013-2014
Darunavir and congenital malformations, using a network meta-analysis approach. 201306DES View
5-HT3 Antagonists (Antiemetics) & Cardiac Safety, using an active surveillance approach. 201306DPR View
Newer antidepressants and persistent pulmonary hypertension of the newborn (PPHN), using a comparative effectiveness approach. 201310DES View
Optimizing Chronic Hepatitis C Treatment Using Pharmacogenomic Biomarkers, using an active surveillance approach. 201310DPR View
Other: Directed Grant: DSEN-CADTH 201308DDC View
Fellowship: Winter 2013 Priority Announcements (Drug Safety and Effectiveness) 201302FDS View
Other: Rapid Funding for DSEN Targeted Research - Prospective Studies (Winter 2013 Competition 201301DPR View
Other: Rapid Funding for DSEN Targeted Research - Network Meta-Analysis (Winter 2013 Competition) 201301DES View
Date modified: